Matinas BioPharma Holdings Inc (MTNB)
0.1655
0.00 (0.00%)
USD |
NYAM |
May 23, 16:00
0.1655
0.00 (0.00%)
After-Hours: 20:00
Matinas BioPharma Holdings Total Assets (Quarterly): 19.61M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.61M |
| December 31, 2023 | 25.10M |
| September 30, 2023 | 29.79M |
| June 30, 2023 | 34.02M |
| March 31, 2023 | 38.26M |
| December 31, 2022 | 44.82M |
| September 30, 2022 | 47.55M |
| June 30, 2022 | 52.42M |
| March 31, 2022 | 55.78M |
| December 31, 2021 | 61.33M |
| September 30, 2021 | 66.98M |
| June 30, 2021 | 69.97M |
| March 31, 2021 | 72.35M |
| December 31, 2020 | 70.97M |
| September 30, 2020 | 74.81M |
| June 30, 2020 | 79.09M |
| March 31, 2020 | 84.11M |
| December 31, 2019 | 40.24M |
| September 30, 2019 | 44.82M |
| June 30, 2019 | 48.21M |
| March 31, 2019 | 50.57M |
| Date | Value |
|---|---|
| December 31, 2018 | 19.94M |
| September 30, 2018 | 14.41M |
| June 30, 2018 | 16.04M |
| March 31, 2018 | 11.49M |
| December 31, 2017 | 14.42M |
| September 30, 2017 | 16.52M |
| June 30, 2017 | 17.80M |
| March 31, 2017 | 22.03M |
| December 31, 2016 | 9.816M |
| September 30, 2016 | 11.31M |
| June 30, 2016 | 5.565M |
| March 31, 2016 | 6.746M |
| December 31, 2015 | 8.406M |
| September 30, 2015 | 9.869M |
| June 30, 2015 | 11.86M |
| March 31, 2015 | 9.798M |
| December 31, 2014 | 3.362M |
| September 30, 2014 | 5.789M |
| June 30, 2014 | 7.363M |
| March 31, 2014 | 9.327M |
| December 31, 2013 | 11.33M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
19.61M
Minimum
Mar 2024
84.11M
Maximum
Mar 2020
53.01M
Average
50.32M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 3.534M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.052M |
| Shareholders Equity (Quarterly) | 14.56M |